Inflammatory diseases of the small intestine are associated with an IL-18 dysregulation condition, and experimental NEC rats, treated with EGF, showed a decrease in the levels of pro-inflammatory cytokines, IL-18, on the intestinal damage site, as well as IL-18 mRNA levels. The gene discussed is IL18; the disease is necrotizing enterocolitis.